Stockmarkets shrug off turbulence
Stockmarkets have hit their first bout of turbulence of the year, but most are clinging onto January’s gains.
The rampage of the Reddit bulls has made more conventional investors take cover. America’s S&P 500 had its worst week since October, closing down 1.9% last Friday. Perhaps most tellingly, the CBOE VIX volatility index, the stockmarket’s “fear gauge”, registered its biggest weekly gain since June last year. The index had stayed beneath 25 for most of the period since Biden’s election victory, but finished last week at 32.4.
For many institutional investors, the spectacle of “retail investors piling into particular stocks” and pushing prices to absurd levels brings back uncomfortable memories of the dotcom bubble, says Rupert Thompson of Kingswood. The drama helped global shares lose almost 4% last week, erasing their gains for the year so far.
The “skirmishes” between hedge funds and Reddit’s “vengeful legions” may have seized the headlines, but financially speaking the whole thing is a rounding error, says Cormac Mullen on Bloomberg. The shares being shorted in the likes of GameStop and other hedge-fund targets amount to “less than 0.001% of the $43trn stockmarket”, according to figures from Barclays. Yet with US equity valuations so high, anything that makes people forget their “greed and fear” and consider “prudence” is salutary.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Markets have hit their first bout of turbulence of the year, but most are clinging onto January’s gains. China’s CSI 300 is up by 4.4% so far this year, while America’s S&P 500 has climbed more than 3.5%. The major laggard has been Europe, where Germany’s DAX has gained just 0.7% for the year. After a strong start the FTSE 100 is marginally down. Therein lies opportunity: British stocks, as MoneyWeek often points out, are trading at a discount to their global peers, and are worth scooping up.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
UK dividends rose in final quarter of 2025, but share buybacks ate into investor payoutsLast year saw dividend growth continue to fall below pre-pandemic averages, against a backdrop of increasing share buybacks.
-
Lifetime ISA reform: Retirement option could be scrapped in overhaulA consultation on a product replacing the Lifetime ISA is set to be launched this year, and the option to use it to save for retirement is expected to be axed in the shake-up
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
How to invest in the new breed of payment providersUpstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves
-
What turns a stock market crash into a financial crisis?Opinion Professor Linda Yueh's popular book on major stock market crashes misses key lessons, says Max King
-
How to add cryptocurrency to your portfolioA new listing shows how bitcoin might add value to a portfolio if cryptocurrency keeps gaining acceptance, says Cris Sholto Heaton
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust